Literature DB >> 21536792

Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha.

Poonam Dharmani1, Jaclyn Strauss, Christian Ambrose, Emma Allen-Vercoe, Kris Chadee.   

Abstract

The etiology of inflammatory bowel disease is not completely known, but it is influenced by the presence of normal gut microflora as well as yet-unrecognized pathogens. The anaerobic, Gram-negative bacterial species Fusobacterium nucleatum is a common resident of the human mouth and gut and varies in its pathogenic potential. In this study, we demonstrate that highly invasive F. nucleatum isolates derived from the inflamed guts of Crohn's disease patients evoked significantly greater MUC2 and tumor necrosis factor alpha (TNF-α) gene expression than minimally invasive strains isolated from the noninflamed gut in human colonic epithelial cells and in a rat ligated colonic loop model of infection. Only live F. nucleatum induced mucin secretion and TNF-α expression in direct contact with and/or during invasion of colonic cells. In rat colons, mucin secretion was augmented in response to a highly invasive F. nucleatum isolate but was unaffected by treatment with a minimally invasive strain. Taken together, these studies reveal that F. nucleatum may represent a challenging pathogen in the etiology of gut inflammatory diseases and highlight the importance of different pathotypes of candidate bacterial species in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536792      PMCID: PMC3191979          DOI: 10.1128/IAI.05118-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility.

Authors:  Simon P Hogan; Luqman Seidu; Carine Blanchard; Katherine Groschwitz; Anil Mishra; Margaret L Karow; Richard Ahrens; David Artis; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2006-07       Impact factor: 10.793

2.  Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice.

Authors:  N V Contractor; H Bassiri; T Reya; A Y Park; D C Baumgart; M A Wasik; S G Emerson; S R Carding
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

3.  Protein secretion systems in Fusobacterium nucleatum: genomic identification of Type 4 piliation and complete Type V pathways brings new insight into mechanisms of pathogenesis.

Authors:  Mickaël Desvaux; Arshad Khan; Scott A Beatson; Anthony Scott-Tucker; Ian R Henderson
Journal:  Biochim Biophys Acta       Date:  2005-07-30

4.  TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation.

Authors:  Dae-ho Ahn; Suzanne C Crawley; Ryota Hokari; Shingo Kato; Stacey C Yang; Jian-Dong Li; Young S Kim
Journal:  Cell Physiol Biochem       Date:  2005

5.  T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment.

Authors:  L Dianda; A M Hanby; N A Wright; A Sebesteny; A C Hayday; M J Owen
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Interaction of LS174T human colon cancer cell mucins with Entamoeba histolytica: an in vitro model for colonic disease.

Authors:  A Belley; K Keller; J Grove; K Chadee
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

Review 7.  Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases.

Authors:  Mahefatiana Andrianifahanana; Nicolas Moniaux; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2006-01-27

8.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Genotypic and phenotypic characterization of fusobacteria from Chinese and European patients with inflammatory periodontal diseases.

Authors:  Rudolf Gmür; Mark A Munson; William G Wade
Journal:  Syst Appl Microbiol       Date:  2005-08-18       Impact factor: 4.022

Review 10.  Sensor molecules in intestinal innate immunity against bacterial infections.

Authors:  Lars Eckmann
Journal:  Curr Opin Gastroenterol       Date:  2006-03       Impact factor: 3.287

View more
  64 in total

1.  Fusobacterium spp. and colorectal cancer: cause or consequence?

Authors:  Temitope O Keku; Amber N McCoy; Andrea M Azcarate-Peril
Journal:  Trends Microbiol       Date:  2013-09-09       Impact factor: 17.079

Review 2.  Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.

Authors:  Arif Bashir; Abid Yousuf Miskeen; Younis Mohammad Hazari; Syed Asrafuzzaman; Khalid Majid Fazili
Journal:  Tumour Biol       Date:  2015-12-30

3.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

Authors:  Aleksandar D Kostic; Eunyoung Chun; Lauren Robertson; Jonathan N Glickman; Carey Ann Gallini; Monia Michaud; Thomas E Clancy; Daniel C Chung; Paul Lochhead; Georgina L Hold; Emad M El-Omar; Dean Brenner; Charles S Fuchs; Matthew Meyerson; Wendy S Garrett
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

Review 4.  Gut microbiota and IBD: causation or correlation?

Authors:  Josephine Ni; Gary D Wu; Lindsey Albenberg; Vesselin T Tomov
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-07-19       Impact factor: 46.802

5.  Functional genomic analyses of the gut microbiota for CRC screening.

Authors:  Sergey R Konstantinov; Ernst J Kuipers; Maikel P Peppelenbosch
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

6.  Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.

Authors:  Giuseppina Liguori; Bruno Lamas; Mathias L Richard; Giovanni Brandi; Gregory da Costa; Thomas W Hoffmann; Massimo Pierluigi Di Simone; Carlo Calabrese; Gilberto Poggioli; Philippe Langella; Massimo Campieri; Harry Sokol
Journal:  J Crohns Colitis       Date:  2015-11-15       Impact factor: 9.071

7.  Beneficial effects of protease preparations derived from Aspergillus on the colonic luminal environment in rats consuming a high-fat diet.

Authors:  Yongshou Yang; Novita Vivi Sitanggang; Norihisa Kato; Junji Inoue; Takayuki Murakami; Toshiro Watanabe; Takafumi Iguchi; Yukako Okazaki
Journal:  Biomed Rep       Date:  2015-07-15

8.  The effects of different high-fat (lard, soybean oil, corn oil or olive oil) diets supplemented with fructo-oligosaccharides on colonic alkaline phosphatase activity in rats.

Authors:  Yukako Okazaki; Tetsuyuki Katayama
Journal:  Eur J Nutr       Date:  2020-03-19       Impact factor: 5.614

9.  Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients.

Authors:  Ellen Teresa Boehm; Cosima Thon; Juozas Kupcinskas; Ruta Steponaitiene; Jurgita Skieceviciene; Ali Canbay; Peter Malfertheiner; Alexander Link
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

10.  Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.

Authors:  L Flanagan; J Schmid; M Ebert; P Soucek; T Kunicka; V Liska; J Bruha; P Neary; N Dezeeuw; M Tommasino; M Jenab; J H M Prehn; D J Hughes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.